- Home
- SEER
SEER
Seer Inc.
as 07-26-2024 4:00pm EST
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 116.9M | IPO Year: | 2020 |
| Target Price: | $7.00 | AVG Volume (30 days): | 918.5K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.46 - $5.13 | Next Earning Date: | 08-08-2024 |
| Revenue: | $15,674,000 | Revenue Growth: | -3.45% |
| Revenue Growth (this year): | 2.78% | Revenue Growth (next year): | 40.46% |
Stock Insider Trading Activity of Seer Inc. (SEER)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nishar Dipchand | SEER | Director | Jun 14 '24 | Sell | $1.78 | 12,109 | $21,511.64 | 79,457 | SEC Form 4 |
| Farokhzad Omid | SEER | CEO AND CHAIR | Mar 7 '24 | Sell | $2.03 | 52,857 | $107,421.28 | 1,436,285 | SEC Form 4 |
| Horn David R. | SEER | PRESIDENT & CFO | Feb 6 '24 | Sell | $1.58 | 12,684 | $20,024.23 | 480,511 | SEC Form 4 |
| Kogan Elona Esq. | SEER | CHIEF LEGAL OFFICER | Feb 6 '24 | Sell | $1.58 | 12,684 | $20,024.23 | 273,142 | SEC Form 4 |
| Horn David R. | SEER | President and CFO | Feb 5 '24 | Sell | $1.67 | 3,608 | $6,014.54 | 328,157 | SEC Form 4 |
| Kogan Elona Esq. | SEER | Chief Legal Officer | Dec 4 '23 | Sell | $1.70 | 8,182 | $13,869.31 | 162,673 | SEC Form 4 |
Latest Seer Inc. News
SEER Breaking Stock News: Dive into SEER Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
Simply Wall St.
a month ago
Will Seer (NASDAQ:SEER) Spend Its Cash Wisely?
GlobeNewswire
a month ago
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
GlobeNewswire
2 months ago
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
GuruFocus.com
3 months ago
Seer Inc (SEER) Q1 2024 Earnings: Revenue Declines but Losses Narrow, Meeting Some Analyst ...
Simply Wall St.
3 months ago
Seer First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Insider Monkey
3 months ago
Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript
Thomson Reuters StreetEvents
3 months ago
Q1 2024 Seer Inc Earnings Call
Compare SEER vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SEER Seer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.